Key result
UCP1 single nucleotide polymorphisms showed no statistically significant association with cardio-metabolic pathologies in the overall multi-country sample, though some population-specific associations were observed.
Why the study?
The contribution of UCP1 single nucleotide polymorphisms to cardiometabolic pathology susceptibility and their involvement in specific risk factors varies across populations.
Case-Control (n=2,283)
Yes
UCP1 genetic polymorphisms may be associated with cardiometabolic pathologies and risk factors in specific populations, although a meta-analysis showed no overall significant association.
Contribution of UCP1 single nucleotide polymorphisms (SNPs) to susceptibility for cardiometabolic pathologies (CMP) and their involvement in specific risk factors for these conditions varies across populations. We tested whether UCP1 SNPs A-3826G, A-1766G, Ala64Thr and A-112C are associated with common CMP and their risk factors across Armenia, Greece, Poland, Russia and United Kingdom. This case-control study included genotyping of these SNPs, from 2,283 Caucasians. Results were extended via systematic review and meta-analysis. In Armenia, GA genotype and A allele of Ala64Thr displayed ~2-fold higher risk for CMP compared to GG genotype and G allele, respectively (p<0.05). In Greece, A allele of Ala64Thr decreased risk of CMP by 39%. Healthy individuals with A-3826G GG genotype and carriers of mutant allele of A-112C and Ala64Thr had higher body mass index compared to those carrying other alleles. In healthy Polish, higher waist-to-hip ratio (WHR) was observed in heterozygotes A-3826G compared to AA homozygotes. Heterozygosity of A-112C and Ala64Thr SNPs was related to lower WHR in CMP individuals compared to wild type homozygotes (p<0.05). Meta-analysis showed no statistically significant odds-ratios across our SNPs (p>0.05). Concluding, the studied SNPs could be associated with the most common CMP and their risk factors in some populations.
No takes yet. Share an insight, caveat, or question.
Dinas et al. (2022) conducted a case-control in Cardio-metabolic pathologies (n=2,283). UCP1 single nucleotide polymorphisms vs. Wild type genotypes / healthy controls was evaluated on Association of Ala64Thr GA genotype with cardio-metabolic pathologies (OR 1.09, 95% CI 0.87-1.37, p=0.203). UCP1 single nucleotide polymorphisms showed no statistically significant association with cardio-metabolic pathologies in the overall multi-country sample, though some population-specific associations were observed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: